Heart regeneration

Michael A. Laflamme and Charles E. Murry ()
Additional contact information
Michael A. Laflamme: Center for Cardiovascular Biology, Institute for Stem Cell and Regenerative Medicine, University of Washington
Charles E. Murry: Center for Cardiovascular Biology, Institute for Stem Cell and Regenerative Medicine, University of Washington

Nature, 2011, vol. 473, issue 7347, 326-335

Abstract: Abstract Heart failure plagues industrialized nations, killing more people than any other disease. It usually results from a deficiency of specialized cardiac muscle cells known as cardiomyocytes, and a robust therapy to regenerate lost myocardium could help millions of patients every year. Heart regeneration is well documented in amphibia and fish and in developing mammals. After birth, however, human heart regeneration becomes limited to very slow cardiomyocyte replacement. Several experimental strategies to remuscularize the injured heart using adult stem cells and pluripotent stem cells, cellular reprogramming and tissue engineering are in progress. Although many challenges remain, these interventions may eventually lead to better approaches to treat or prevent heart failure.

Date: 2011
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature10147 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:473:y:2011:i:7347:d:10.1038_nature10147

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature10147

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().